Foodborne Diseases Treatment Market Size and Growth Rate:

“The Global Foodborne Diseases Treatment Market is expected to reach US$ 9,897.8 Mn by 2025 owing to growth in R&D for the development of newer drugs”

Foodborne Diseases Treatment Market Growth Drivers and Restraints:

The global foodborne diseases treatment market is expected to reach US$ 9,897.8 Mn by 2025. Foodborne diseases cover a broad spectrum of illnesses that are affecting the people worldwide. These diseases are due to the intake of food contaminated with harmful microorganisms or chemicals. The major factors streaming the growth of global foodborne diseases treatment market are rise in prevalence of foodborne diseases globally and increase in research and development activities. According to a report published by WHO in June 2019, an estimated 600 million people in the world fall ill after eating contaminated food and 4,20,000 die every year, resulting in the loss of 33 million healthy life years (DALYs). Furthermore, children under 5 years of age carry 40% of the foodborne disease burden, with 125,000 deaths every year. Due to lack of hygienic condition in which the food are prepared both governmental and non-governmental organizations are taking initiatives to create awareness among people.

On the flip side high cost of research, low awareness about the hygienic food, and strict regulatory procedures restricts the market over the forecast period.

Browse More Details of the report @ https://www.precisionbusinessinsights.com/market-reports/global-foodborne-diseases-treatment-market/

Diarrhea Dominate the Global Foodborne Diseases Treatment Market

Based on the disease type, global foodborne diseases treatment market is segmented into Botulism, Diarrhea, Gastroenteritis, Toxoplasmosis, and Others. Diarrhea dominated the global foodborne diseases treatment market. According to report published by WHO in June 2019, diarrheal diseases are the most common illnesses resulting from the consumption of contaminated food, causing 550 million people to fall ill and 230 000 deaths every year, thus more research activities are driven towards this segment leading to its market growth.

North America Leads the Global Foodborne Diseases Treatment Market

PBI’s global foodborne diseases treatment market report analyses the market in different regions such as North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. According to regional analysis, North America dominated the global foodborne diseases treatment market through 2014-2018 and expected to dominate over 2019-2025 due rising prevalence of foodborne diseases in the region, well established healthcare system, and more availability of treatment options. A report issued in June 2018, by NBC's Minneapolis station concluded that foodborne illness is on the rise in the U.S. The CDC has reported approximately 4,000 cases of food poisoning annually. After North America, Europe dominates the global foodborne diseases treatment market due to increased number of death caused by foodborne bacteria especially E. coli. In May 2015, England’s Food Standards Agency devoted its annual Food Safety Week to create awareness on the handling of raw chicken in the home and in catering facilities to reduce the high levels of food poisoning from the campylobacter bacterium. Middle East and Africa foodborne diseases treatment market is expected to grow at significant growth rate due to lack of awareness about hygienic in some countries.
Launch of newer drug products, and strategic alliances are the key strategies adopted by market players

Global Foodborne Diseases Treatment market further reveals that the key player’s increasingly adopting strategies such as launch of newer drugs, and long term alliance to improve market revenue share and gaining significant geographic presence across the region.
 For instance, in 2015, January, Valneva SE, entered a purchase and sale with Crucell Holland B.V. in order to acquire Crucell Sweden AB and privileges and licenses of dukoral vaccine to treat cholera and traveler’s diarrhea.

Key player’s profiles in the report are Bayer AG (Germany), Morphotek Inc. (U.S.), Johnson & Johnson Services Inc., (U.S.), Molecular Targeting Technologies, Inc. (U.S.), Valneva SE (Europe), Merck & Co., Inc. (U.S.), AlphaVax, Inc. (U.S.), GlaxoSmithKline plc (U.K), XOMA Corporation (U.S.), and Novartis AG (Switzerland).

Ask For Sample of the report @ https://www.precisionbusinessinsights.com/request-sample?product_id=15725

Detailed Segmentation of Foodborne Diseases Treatment Market:

By Drug Class
• Antibiotics
• Anti-Diarrhea
• Fluids and Electrolyte Replenishers
• Vaccines
• Others

By Disease Type
• Botulism
• Diarrhea
• Gastroenteritis
• Toxoplasmosis
• Others

By Route of Administration
• Parenteral
• Oral
• Others

By Distribution Channels
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Geography

o North America
o Europe
o Asia-Pacific
o Latin America
o Middle East and Africa (MEA)

About Us:

Precision Business Insights is one of the leading market research and management consulting firm, run by a group of seasoned and highly dynamic market research professionals with a strong zeal to offer high-quality insights.

Contact Us:

Shreya Paul
Senior Business Development Executive
Email @ [email protected]
Call @ +1-866-598-1553
Precision Business Insights